|
15.01.2024 18:59:59
|
EQS-AFR: SCHOTT Pharma AG & Co. KGaA: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
|
EQS Preliminary announcement financial reports: SCHOTT Pharma AG & Co. KGaA
/ Preliminary announcement on the disclosure of financial statements
SCHOTT Pharma AG & Co. KGaA hereby announces that the following financial reports shall be disclosed:
Report Type: Annual financial report Language: German Date of disclosure: January 26, 2024 Address: https://www.schott-pharma.com/investor-relations/de/news-und-veroeffentlichungen/berichte-und-praesentationen/ Language: English Date of disclosure: January 26, 2024 Address: https://www.schott-pharma.com/investor-relations/news-publications/reports-and-presentations/ Report Type: Annual financial report of the group Language: German Date of disclosure: January 26, 2024 Address: https://www.schott-pharma.com/investor-relations/de/news-und-veroeffentlichungen/berichte-und-praesentationen/ Language: English Date of disclosure: January 26, 2024 Address: https://www.schott-pharma.com/investor-relations/news-publications/reports-and-presentations/ Report Type: Financial report of the group (half-year/Q2) Language: German Date of disclosure: June 27, 2024 Address: https://www.schott-pharma.com/investor-relations/de/news-und-veroeffentlichungen/berichte-und-praesentationen/ Language: English Date of disclosure: June 27, 2024 Address: https://www.schott-pharma.com/investor-relations/news-publications/reports-and-presentations/
15.01.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | SCHOTT Pharma AG & Co. KGaA |
| Hattenbergstraße 10 | |
| 55122 Mainz | |
| Germany |
| End of News | EQS News Service |
|
|
1815447 15.01.2024 CET/CEST
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu SCHOTT Pharmamehr Nachrichten
|
09:31 |
WDH/ROUNDUP: Schott Pharma will mit margenstarken Produkten wachsen (dpa-AFX) | |
|
09:29 |
Freundlicher Handel in Frankfurt: MDAX verbucht zum Start Gewinne (finanzen.at) | |
|
09:26 |
ROUNDUP: Schott Pharma will mit margenstarken Produkten wachsen - Aktie fällt (dpa-AFX) | |
|
09:04 |
ANALYSE-FLASH: UBS belässt Schott Pharma auf 'Neutral' - Ziel 32,60 Euro (dpa-AFX) | |
|
08:54 |
AKTIE IM FOKUS: Schott Pharma legen nach Zahlen zu - Aktie bisher sehr schwach (dpa-AFX) | |
|
08:02 |
Schott Pharma will Aktionären mehr Dividende auszahlen (dpa-AFX) | |
|
07:47 |
Schott Pharma will bei ähnlicher Marge mehr erlösen (dpa-AFX) | |
|
07:00 |
EQS-News: SCHOTT Pharma erreicht starkes Wachstum und Rekordmarge nach gutem Jahresendspurt (EQS Group) |
Analysen zu SCHOTT Pharmamehr Analysen
| 08:33 | SCHOTT Pharma Hold | Jefferies & Company Inc. | |
| 08:21 | SCHOTT Pharma Neutral | UBS AG | |
| 11.12.24 | SCHOTT Pharma Hold | Jefferies & Company Inc. | |
| 25.11.24 | SCHOTT Pharma Neutral | UBS AG | |
| 11.09.24 | SCHOTT Pharma Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.